07:00 , Jul 21, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: MicroRNA-1246 (miR-1246); miR-1290

Cancer INDICATION: Non-small cell lung cancer (NSCLC) Patient sample, cell culture and mouse studies suggest inhibiting miR-1246 or miR-1290 could help treat NSCLC. In lung tissue samples from NSCLC patients, levels of miR-1246 and miR-1290 were higher...